Management and Treatment for Tuberculosis Laten |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.15, No. 2)Publication Date: 2021-12-23
Authors : Nanda Rachmad Putra Gofur; Aisyah Rachmadani Putri Gofur; Soesilaningtyas; Rizki Nur Rachman Putra Gofur; Mega Kahdina; Hernalia Martadila Putri;
Page : 229-233
Keywords : SDGs; Tuberculosis; Management; Treatment; Drug choice;
Abstract
Introduction: Pulmonary tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. This bacterium is in the form of a bacillus and is acid-fast, so it is also known as an acid-fast bacillus (BTA). Pulmonary TB mainly attacks the lungs as the site of primary infection, in addition, tuberculosis can also attack the skin, lymph nodes, bones, and the lining of the brain. Pulmonary TB is transmitted through infectious droplets inhaled by healthy people. Aims of this study is to review management of Tuberculosis.
Other Latest Articles
- Polybrominated diphenyl ethers’ exposure causes changes in the physiology of zebra mussel, Dreissena polymorpha (Pallas, 1771)
- Metagenomic approach unravelling bacterial diversity in combined composting and vermicomposting technology of agricultural wastes
- Preoperative Level of Insulin-Like Growth Factor Binding Protein 2 Predicts The Suboptimal Outcome After Primary Debulking Surgery in Patients with Advance Ovarian Cancer
Last modified: 2023-12-14 21:58:36